Include Sublocade for Opioid Use Disorder in Patient Profiles

Sublocade (SUB-loh-kayd) will be the first once-monthly buprenorphine INJECTION for opioid use disorder.

Expect Sublocade to be saved for patients who are stable on a sublingual or buccal buprenorphine-containing product (Suboxone, etc) for at least a doses equivalent to 8 to 24 mg/day.

Be aware that Sublocade will be available through certain specialty pharmacies...and it must be administered by a healthcare provider. Plus it costs $1,600/month.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote